US1101221083
Impact Score
Bristol-Myers Squibb is a global biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for serious diseases.
Impact Score
Metric | Value | Unit | Year | PDF Name | PDF Page | |
---|---|---|---|---|---|---|
CEO-to-Employee Pay Ratio | ||||||
Chris Boerner | 2023 | 2023-bms-annual-report.pdf | 3 | |||
130 | Ratio | 2023 | bms-2024-definitive-proxy-statement.pdf | 93 | ||
Gender Pay Gap | ||||||
99 | % | 2023 | BMS-ESG-Report-2023 (1).pdf | 61 | ||
Glass Ceiling | ||||||
52,1 | % | 2023 | BMS-ESG-Report-2023 (1).pdf | 60 | ||
56,8 | % | 2023 | BMS-ESG-Report-2023 (1).pdf | 60 | ||
Greenhouse Gas Emissions | ||||||
34 100 | Absolute | 2023 | BMS-ESG-Report-2023 (1).pdf | 105 | ||
366 981 | (Metric Tons | 2023 | BMS-ESG-Report-2023 (1).pdf | 119 | ||
Harassment and Discrimination at the Workplace | ||||||
Yes | 2023 | BMS-ESG-Report-2023 (1).pdf | 76 | |||
Yes | 2023 | BMS-ESG-Report-2023 (1).pdf | 72 | |||
Yes | 2023 | principles-of-integrity.pdf | 6 | |||
Neutral | 2023 | principles-of-integrity.pdf | 12 | |||
Supply Chain | ||||||
1 750 947 | (Metric Tons | 2023 | BMS-ESG-Report-2023 (1).pdf | 119 | ||
366 981 | (Metric Tons | 2023 | BMS-ESG-Report-2023 (1).pdf | 119 | ||
34 100 | Absolute | 2023 | BMS-ESG-Report-2023 (1).pdf | 105 | ||
Recycling and Recovery of Waste | ||||||
5 925 | (Metric Tons CO2e) | 2023 | BMS-ESG-Report-2023 (1).pdf | 120 | ||
11 479 | (Metric Tons CO2e) | 2023 | BMS-ESG-Report-2023 (1).pdf | 120 | ||
Women on the Board | ||||||
6 | Absolute | 2023 | f3f54310-82c7-4a89-9135-e26704422697.pdf | 39 | ||
13 | Absolute | 2023 | f3f54310-82c7-4a89-9135-e26704422697.pdf | 39 | ||
12 | Absolute | 2023 | 2023-bms-annual-report.pdf | 102 | ||
4 | Absolute | 2023 | 2023-bms-annual-report.pdf | 102 | ||
Women in Management | ||||||
52,1 | % | 2023 | BMS-ESG-Report-2023 (1).pdf | 60 |